| Metric | FY 2020 | Prior Q | FY 2019 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $955M | — | $868M | — | 10.1% |
| Op. Income | $490M | — | $659M | — | -25.6% |
| Gross Margin | 68.5% | — | 96.2% | — | -27.7pp |
| Net Margin | 43.2% | — | 64.1% | — | -20.8pp |
| EPS (Diluted) | $3.88 | — | $5.66 | — | -31.4% |
| Free Cash Flow | $725M | — | $586M | — | 23.7% |
| Item | Amount |
|---|---|
| REVENUE | $955M |
| Cost of Revenue | $301M |
| GROSS PROFIT | $654M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $93M |
| SG&A Expenses | $93M |
| Other Expenses | $71M |
| Operating Expenses | $164M |
| Cost & Expenses | $465M |
| OPERATING INCOME | $490M |
| Interest Income | $0 |
| Interest Expense | $9M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $490M |
| Income Tax Expense | $77M |
| Net Income from Continuing Ops | $413M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $413M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $413M |
| D&A | $3M |
| EBIT | $499M |
| EBITDA | $502M |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| REVENUE | $955M |
| Cost of Revenue | $301M |
| GROSS PROFIT | $654M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $93M |
| SG&A Expenses | $93M |
| Other Expenses | $71M |
| Operating Expenses | $164M |
| Cost & Expenses | $465M |
| OPERATING INCOME | $490M |
| Interest Income | $0 |
| Interest Expense | $9M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $490M |
| Income Tax Expense | $77M |
| Net Income from Continuing Ops | $413M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $413M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $413M |
| D&A | $3M |
| EBIT | $499M |
| EBITDA | $502M |
| EPS | $4 |
| EPS Diluted | $4 |
| Item | Amount |
|---|---|
| Net Income | $413M |
| Depreciation & Amortization | $3M |
| Stock-Based Compensation | $18M |
| Deferred Income Tax | $39M |
| Other Non-Cash Items | $22M |
| Change in Working Capital | $232M |
| OPERATING CASH FLOW | $728M |
| Capital Expenditure | -$2M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$2.0B |
| Sales/Maturities of Investments | $852M |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$1.2B |
| Net Debt Issuance | $100M |
| Common Stock Repurchased | -$6M |
| Common Dividends Paid | -$69M |
| Other Financing Activities | -$6M |
| NET CASH FROM FINANCING | $458M |
| FREE CASH FLOW | $725M |
| Net Change in Cash | $31M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $103M |
| Short-Term Investments | $4.6B |
| Net Receivables | $50M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $4.7B |
| PP&E (Net) | $15M |
| Goodwill | $0 |
| Intangible Assets | $20M |
| Long-Term Investments | -$4.5B |
| Tax Assets | -$20M |
| Other Non-Current Assets | $9.0B |
| TOTAL NON-CURRENT ASSETS | $4.6B |
| TOTAL ASSETS | $5.2B |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $234M |
| TOTAL CURRENT LIABILITIES | $322M |
| Long-Term Debt | $322M |
| Deferred Revenue NC | -$732M |
| Deferred Tax Liabilities | $305M |
| Other Non-Current Liabilities | $732M |
| TOTAL NON-CURRENT LIABILITIES | $627M |
| TOTAL LIABILITIES | $1.3B |
| Common Stock | $2M |
| Additional Paid-In Capital | $1.6B |
| Retained Earnings | $2.2B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $138M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $3.9B |
| Minority Interest | $0 |
| TOTAL EQUITY | $3.9B |
| TOTAL LIABILITIES & EQUITY | $5.2B |
| Total Debt | $322M |
| Net Debt | $219M |
